Literature DB >> 22465663

MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.

Li Wang1, Ming Shi, Shuangxing Hou, Bojun Ding, Lijuan Liu, Xituan Ji, Jian Zhang, Yanchun Deng.   

Abstract

MicroRNAs (miRNAs) exhibit tumor-specific expression signatures and play crucial roles in tumorigenesis by targeting oncogenes. Here, through analyzing the miRNA-array profiles of human glioblastoma tissues and the adjacent normal brain tissues, we found miR-483-5p was significantly down-regulated in gliomas, which was confirmed in both human glioma specimens and cell lines. The overexpression of miR-483-5p suppressed glioma cell proliferation and induced a G0/G1 arrest. In contrast, miR-483-5p inhibition promoted cell proliferation. Furthermore, by a dual-luciferase reporter assay and expression analysis, we identified extracellular signal-regulated kinase 1 (ERK1) as a direct target of miR-483-5p. ERK1 knockdown can block cell proliferation induced by miR-483-5p inhibition. Thus, our findings provide the first evidence that miR-483-5p can serve as a tumor suppressor in gliomas.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465663     DOI: 10.1016/j.febslet.2012.03.035

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  36 in total

Review 1.  microRNAs in cancer cell response to ionizing radiation.

Authors:  Jennifer R Czochor; Peter M Glazer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

Review 2.  Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.

Authors:  L Saadatpour; E Fadaee; S Fadaei; R Nassiri Mansour; M Mohammadi; S M Mousavi; M Goodarzi; J Verdi; H Mirzaei
Journal:  Cancer Gene Ther       Date:  2016-11-11       Impact factor: 5.987

3.  miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.

Authors:  Ming He; Zhen Chen; Marcy Martin; Jin Zhang; Panjamaporn Sangwung; Brian Woo; Adriana H Tremoulet; Chisato Shimizu; Mukesh K Jain; Jane C Burns; John Y-J Shyy
Journal:  Circ Res       Date:  2016-12-06       Impact factor: 17.367

4.  Screening of potential biomarkers for chemoresistant ovarian carcinoma with miRNA expression profiling data by bioinformatics approach.

Authors:  Shiyang Wei; Yafeng Wang; Hong Xu; Yan Kuang
Journal:  Oncol Lett       Date:  2015-08-14       Impact factor: 2.967

5.  miR-1 induces growth arrest and apoptosis in malignant mesothelioma.

Authors:  Yue Xu; Ming Zheng; Robert E Merritt; Joseph B Shrager; Heather A Wakelee; Robert A Kratzke; Chuong D Hoang
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

6.  Exploring the underlying molecular mechanism of liver cancer cells under hypoxia based on RNA sequencing.

Authors:  Xin Zhao; Wenpeng Liu; Baowang Liu; Qiang Zeng; Ziqiang Cui; Yang Wang; Jinglin Cao; Qingjun Gao; Caiyan Zhao; Jian Dou
Journal:  BMC Genom Data       Date:  2022-05-19

7.  A six-microRNA set as prognostic indicators for bile duct cancer.

Authors:  Ming Wang; Tian-Fu Wen; Lin-Hai He; Chuan Li; Wen-Jiang Zhu; Narasimha Murthy Trishul
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.

Authors:  Sandhya B Rani; Sachin Shivaji Rathod; Shanmuganandam Karthik; Navjot Kaur; Dattatraya Muzumdar; Anjali S Shiras
Journal:  Neuro Oncol       Date:  2013-06-28       Impact factor: 12.300

9.  Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis.

Authors:  Shivaprasad Shwetha; K Gouthamchandra; Madhavi Chandra; B Ravishankar; M N Khaja; Saumitra Das
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling.

Authors:  Carmen Sánchez-Jiménez; Isabel Carrascoso; Juan Barrero; José M Izquierdo
Journal:  BMC Mol Biol       Date:  2013-02-06       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.